✦ LIBER ✦

Associations Between Genetic Polymorphisms of Epidermal Growth Factor Receptor (EGFR) and Survival of Colorectal Cancer (CRC) Patients Treated with 5-Fluorouracil-Based Chemotherapy

✍ Scribed by Ching-Yu Lai MS, Fung-Chang Sung PhD, Ling-Ling Hsieh PhD, Reiping Tang MD, Hung-Yi Chiou PhD, Fang-Yang Wu PhD, Chih-Ching Yeh PhD, MSPH

Book ID: 120963667
Publisher: Springer
Year: 2013
Tongue: English
Weight: 277 KB
Volume: 20
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-013-3069-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of Clinical Prognostic Factors

Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil—Based Chemotherapy

✍ Ana L. Yuste; Jorge Aparicio; Angel Segura; Pedro López-Tendero; Regina Gironés; 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

Biomarker analysis in stage III–IV (M0)

Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

✍ Kim, J-S; Kim, M-A; Kim, T M; Lee, S-H; Kim, D-W; Im, S-A; Kim, T-Y; Kim, W H; Y 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

Cetuximab (C225, Erbitux) in combination

Cetuximab (C225, Erbitux) in combination with irinotecan, infusional 5-fluorouracil (5-FU) and folinic acid (FA) is safe and active in patients (pts) with metastatic colorectal cancer (CRC) expressing epidermal growth factor-receptor (EGFR). Results of a phase I study

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 306 KB

3019 POSTER Association of gene copy num

3019 POSTER Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab monotherapy

✍ J. Berlin; J.R. Hecht; M. Reiner; M. Mullenix; S. Suggs; R. Radinsky; D. Freeman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Epidermal growth factor receptor intron

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

✍ Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Sook Ryun Park; Keun-Wook Lee; Hong Suk So 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

289 Phase II study of cetuximab combined

289 Phase II study of cetuximab combined with FOLFIRI (bi-weekly irinotecan plus infusional 5-FU and folinic acid (FA) in patients (pts) with metastatic, Epidermal growth factor receptor (EGFR)-expressing colorectal cancer (CRC)

✍ J.L. Raoul; J.L. van Laethem; E. Mitry; C. Brezault; F. Husseini; L. Cals; M. Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB